TY - JOUR
T1 - Intravitreal bevacizumab in a patient with a macular star in malignant hypertension
AU - Zucchiatti, Ilaria
AU - Iacono, Pierluigi
AU - Parodi, Maurizio Battaglia
AU - Cascavilla, Maria Lucia
AU - Kontadakis, Dimitris Stelios
AU - Bandello, Francesco
PY - 2011/5
Y1 - 2011/5
N2 - Purpose. To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB). Methods. A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB. Results. Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus bio-microscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably. Conclusions. Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.
AB - Purpose. To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB). Methods. A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB. Results. Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus bio-microscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably. Conclusions. Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.
KW - Intravitreal bevacizumab
KW - Malignant hypertension
KW - Vascular endothelial growth factor
UR - http://www.scopus.com/inward/record.url?scp=79953663139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953663139&partnerID=8YFLogxK
U2 - 10.5301/EJO.2010.5819
DO - 10.5301/EJO.2010.5819
M3 - Article
C2 - 20954147
AN - SCOPUS:79953663139
VL - 21
SP - 336
EP - 339
JO - European Journal of Ophthalmology
JF - European Journal of Ophthalmology
SN - 1120-6721
IS - 3
ER -